Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine
The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots.
Related Articles
When It’s This Hot, ‘We Are Enduring, Not Living’
How one man gets by in the unbearable and inescapable heat of Pakistan’s biggest and most unlivable city.
UnitedHealth’s Campaign to Quiet Critics
The company has invoked the murder of an executive last year to complain about coverage in news outlets, on streaming services and on social media.
UnitedHealth’s Campaign to Quiet Critics
The company has invoked the murder of an executive last year to complain about coverage in news outlets, on streaming services and on social media.
A Surgeon Shares What She Saw in Gaza’s Hospitals
Dr. Victoria Rose spent 21 days in the territory in May, treating people who were shot trying to get food and children with life-changing injuries…
ICE Set to Vastly Expand Its Reach With New Funds
After the passage of President Trump’s domestic policy law, the Department of Homeland Security is poised to hire thousands of new immigration agents and double…
How Health Care Remade the U.S. Economy (Gift Article)
Medicine is now the nation’s largest employer, but its growth may be slowing.
How Health Care Remade the U.S. Economy (Gift Article)
Medicine is now the nation’s largest employer, but its growth may be slowing.
How tennis stars get the rackets, strings and tensions they need for Wimbledon success
Over 6,000 restrings, tiny variances in string tension and customized logos: How Wimbledon gets its stars’ rackets ready for play.
RFK Jr. Cancels Meeting of Key Preventive Health Panel (Gift Article)
The task force recommends which screenings and other preventive health measures must be covered by insurance.
Life Expectancy in California Has Not Rebounded After Covid
The state’s life expectancy was lower in 2024 than in 2019, according to an analysis, but primarily as a result of causes of death other…
